Ebola Cases Confirmed in Congo and Uganda as Suspected Totals Fall
The World Health Organization reported 321 confirmed Ebola cases and 116 suspected cases in Congo on Tuesday. Uganda confirmed six additional cases, bringing its total to 15.
rte.ieThe World Health Organization reported 321 confirmed Ebola cases and 116 suspected cases in the Democratic Republic of Congo on Tuesday. The number of suspected cases dropped from more than 1,100 after investigations ruled out hundreds of them.
At least 48 people have died from the virus in Congo and six have recovered. WHO spokesperson Christian Lindmeier said patients whose cases were ruled out had either other diseases or fever with no additional symptoms.
Ministry of Health confirmed six more cases, bringing the country’s total to 15. Officials are monitoring 668 contacts of confirmed cases. One person has died in Uganda and 12 remain hospitalized.
CEPI announced funding for Moderna, University of Oxford researchers, and the International AIDS Vaccine Initiative to develop new Ebola vaccines. The organizations expect candidate vaccines to reach clinical trials within months. There are no approved treatments or vaccines for the Bundibugyo variant of Ebola currently circulating.
Transparency
Some ideological spread among the sources; broader cross-spectrum confirmation would strengthen it.
Story details
Related Stories
thehindu.comU.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect
A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.
prnewswire.comFed Chairman Names Two Outside Advisers During Transition
Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…